The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation (Q33365990)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation |
scientific article |
Statements
1 reference
The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation (English)
1 reference
G Gerken
1 reference
M van Zonneveld
1 reference
H J Flink
1 reference
E Verhey
1 reference
H Senturk
1 reference
S Zeuzem
1 reference
U S Akarca
1 reference
Y Cakaloglu
1 reference
C Simon
1 reference
T M K So
1 reference
R A de Man
1 reference
S W Schalm
1 reference
H L A Janssen
1 reference
HBV 99-01 Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference